Literature DB >> 5076253

Placental lactogen levels as guide to outcome of threatened abortion.

P A Niven, J Landon, T Chard.   

Abstract

The clinical value has been assessed of circulating placental lactogen levels as a pointer to the outcome in a patient with vaginal bleeding in early pregnancy. By using a semiautomated radioimmunoassay the normal range of values for the first and second trimesters has been established. In patients admitted with vaginal bleeding after the eighth week of gestation estimation of plasma human placental lactogen showed that patients with low levels were those in whom the abortion was completed during the first admission. Women whose pregnancies continued normally or who aborted after their first discharge from hospital had normal levels. In a small group sampled before the onset of bleeding but who later aborted the mean levels were lower than normal. This simple and inexpensive test can indicate those women in whom abortion is inevitable and could be used to reduce substantially the length of hospital stay in this common complication of early pregnancy.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5076253      PMCID: PMC1786352          DOI: 10.1136/bmj.3.5830.799

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  7 in total

1.  Use of human-placental-lactogen radioimmunoassay to predict outcome in cases of threatened abortion.

Authors:  A R Genazzani; M L Aubert; M Casoli; P Fioretti; J P Felber
Journal:  Lancet       Date:  1969-12-27       Impact factor: 79.321

2.  Human placental lactogen. An index of placental function.

Authors:  W Singer; P Desjardins; H G Friesen
Journal:  Obstet Gynecol       Date:  1970-08       Impact factor: 7.661

3.  Serum placental lactogen (HPL) levels as an index of placental function.

Authors:  B N Saxena; K Emerson; H A Selenkow
Journal:  N Engl J Med       Date:  1969-07-31       Impact factor: 91.245

4.  Serum placental lactogen (HPL) as index of placental function.

Authors:  J Spona; H Janisch
Journal:  Acta Endocrinol (Copenh)       Date:  1971-10

5.  Human chorionic somatomammotrophin radioimmunoassay in evaluation of placental function.

Authors:  A R Genazzani; F Cocola; M Casoli; G Mello; G Scarselli; P Neri; P Fioretti
Journal:  J Obstet Gynaecol Br Commonw       Date:  1971-07

6.  A rapid semi-automated method for the measurement of human chorionic somatomammotrophin. The normal range in the third trimester and its relation to fetal weight.

Authors:  A T Letchworth; R J Boardman; C Bristow; J Landon; T Chard
Journal:  J Obstet Gynaecol Br Commonw       Date:  1971-06

7.  Radioimmunoassay of human chorionic somatomammatropin (HCS) plasma levels in normal and abnormal pregnancies.

Authors:  F Haour; M Cohen; J Bertrand
Journal:  Rev Eur Etud Clin Biol       Date:  1971-02
  7 in total
  6 in total

1.  Human Placental Lactogen (HPL).

Authors:  J Franco
Journal:  Calif Med       Date:  1973-09

2.  Monitoring the fetoplacental unit. The placenta.

Authors:  T Chard
Journal:  Postgrad Med J       Date:  1975-04       Impact factor: 2.401

3.  [Diagnosis and treatment of early pregnancy complications (proceedings)].

Authors:  J Zander; B Nitsch
Journal:  Arch Gynakol       Date:  1977-07-29

4.  The prognostic value of human placental lactogen levels in threatened abortion in general practice.

Authors:  D W Gau; G Gau
Journal:  J R Coll Gen Pract       Date:  1977-02

5.  Assessment of fetoplacental function by biochemical determinations.

Authors:  T Chard
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1976

6.  Alpha-fetoprotein in abortion.

Authors:  M Seppälä; E Ruoslahti
Journal:  Br Med J       Date:  1972-12-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.